A brain tumor that turned out to be liver cancer that had spread
Original title: Intracranial metastasis of hepatocellular carcinoma with SMARCA4/BRG1 deficiency: A case report of a young patient easily misdiagnosed as atypical teratoid/rhabdoid tumor.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This is a report about one patient, not a new treatment.
The short version
Doctors report one young patient whose brain tumor was first given the wrong name.
What was studied. This is a report about one young patient. The patient first had bleeding in the brain. Doctors looked at the tumor tissue to name it.
What they found. At first, doctors thought it was a tumor called atypical teratoid/rhabdoid tumor. More testing showed it was liver cancer that had spread to the brain. The tumor was missing a protein called SMARCA4/BRG1. Liver cancer missing this protein is rare, less than 1% of cases.
What this means, and what it doesn't
What it could mean: When a brain tumor is missing SMARCA4/BRG1, doctors may want to check the liver too. Getting the right name for a tumor helps doctors plan the right care.
What it doesn't mean: This is one patient's story, not a study of a treatment. No drug was tested here, and this is not a cure. It does not show how often this happens. It is a long way from changing everyday care.
Source: PubMed, September 25, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.